InvestorsHub Logo
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

Re: horselover45 post# 108941

Tuesday, 01/22/2013 10:05:50 PM

Tuesday, January 22, 2013 10:05:50 PM

Post# of 345954
Andy, I agree with his estimate. If the gemcitabine control arm has a MOS of about 6.5 months then a
MOS of 11.5 months for the bavi + gem arm would be a new record for increased number of months and
percentage increase. It still might not be statistically significant due to the small number of patients in
each arm, but it should get the go ahead for a phase 3 trial.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News